Brief: Regulus Therapeutics Reports First Quarter 2023 Financial Results And Recent Updates
11/05/2023 21:55
Regulus Therapeutics Inc RGLS.O :
* REGULUS THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND RECENT UPDATES
* REGULUS THERAPEUTICS INC - EXPECTED TO EXTEND CASH RUNWAY
INTO
MID-2024
* REGULUS THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.42
Source text for Eikon: ID:nPnc8Y8MPa
Further company coverage: RGLS.O
Recent news on Regulus Therapeutics
See all newsBrief: Novartis Completes Acquisition Of Regulus Therapeutics
Brief: Novartis Announces Expiration Of Hart-Scott-Rodino Waiting Period Of Regulus Therapeutics Tender Offer
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Regulus Therapeutics
Regulus Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Regulus Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview